Found: 3
Select item for more details and to access through your institution.
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
- Published in:
- European Journal of Gynaecological Oncology, 2023, v. 44, n. 1, p. 17, doi. 10.22514/ejgo.2023.002
- By:
- Publication type:
- Article
Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2017, v. 28, n. 6, p. 1, doi. 10.3802/jgo.2017.28.e82
- By:
- Publication type:
- Article
Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers.
- Published in:
- Journal of Gynecologic Oncology, 2016, v. 27, n. 5, p. 1, doi. 10.3802/jgo.2016.27.e47
- By:
- Publication type:
- Article